59 results
8-K
EX-99.1
FRTX
Fresh Tracks Therapeutics, Inc.
11 Aug 23
Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:02pm
agency actions, feedback, or requests; supply chain disruptions; unanticipated demands on cash
resources; and other risks associated with (i
8-K
EX-99.1
FRTX
Fresh Tracks Therapeutics, Inc.
21 Jul 23
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix
8:02am
agency actions, feedback, or requests; supply chain disruptions; unanticipated demands on cash resources; the outcome of and reaction to Fresh Tracks
8-K
EX-99.1
FRTX
Fresh Tracks Therapeutics, Inc.
10 May 23
Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
actions, feedback, or requests; supply chain disruptions; unanticipated demands on cash resources; interruptions, disruption, or inability by Fresh
8-K
EX-99.1
08ham185
30 Mar 23
Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022
4:03pm
8-K
EX-99.1
d4nzqhopj n0g6lc1zm
10 Nov 22
Fresh Tracks Therapeutics Reports Third Quarter 2022
4:10pm
8-K
EX-99.1
adjpo
11 Aug 22
Brickell Biotech Reports Second Quarter 2022
4:09pm
8-K
EX-99.1
7xn ty9pel2ht77y
5 Jul 22
Brickell Biotech Announces 1-For-45 Reverse Stock Split
4:06pm
8-K
ziuj9f8zyh43s2
15 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:01am
8-K
EX-99.1
4fm03 e4fz05rr7
12 May 22
Brickell Biotech Reports First Quarter 2022
4:05pm
DEFA14A
0z6 pkavi8e8a
3 May 22
Additional proxy soliciting materials
4:22pm
8-K
iwg1p3jhhlihjm66vzu
3 May 22
Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders
4:15pm
8-K
EX-99.1
k8ovcgw
3 May 22
Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders
4:15pm
8-K
EX-10.2
qoayq
3 May 22
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
4:08pm